JAMES CAMERON MARTIN

Allopathic & Osteopathic Physicians|Family Medicine SHELBY TOWNSHIP, MI NPI 1285653170

General Payments — all program years on this page

$1,608.15

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 97
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $398.97 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $398.9721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $172.7713
2019 $190.9714
2020 $61.595
2021 $121.257
2022 $174.4010
2023 $488.2027
2024 $398.9721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086145207 Bayer Healthcare Pharmaceuticals Inc. $20.48 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086188242 Bayer Healthcare Pharmaceuticals Inc. $22.12 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096714317 Novo Nordisk Inc $22.13 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096715575 Novo Nordisk Inc $16.64 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096719276 Novo Nordisk Inc $14.76 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096957771 Novo Nordisk Inc $14.00 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097257999 Novo Nordisk Inc $20.86 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104973203 ABBVIE INC. $18.93 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104973205 ABBVIE INC. $27.50 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104973207 ABBVIE INC. $17.22 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117319884 Amgen Inc. $15.68 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124956654 Abbott Laboratories $18.71 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131164419 PFIZER INC. $17.12 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134992534 Lilly USA, LLC $14.63 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135037185 Lilly USA, LLC $18.76 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135038199 Lilly USA, LLC $13.36 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139397299 Astellas Pharma US Inc $21.93 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145943138 Lundbeck LLC $16.09 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150124415 SHIELD THERAPEUTICS INC $21.47 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152386162 Kestra Medical Technology Services, Inc. $22.26 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153305967 Dexcom, Inc. $24.32 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.